Markets › United States › NAS › ACRS

Aclaris Therapeutics Inc

NAS:ACRSHealthcareCBOEFTSE:MRUTNASDAQ:NBI

$3.70−3.52%LiveIn session · ≈ AED 13.57 · Market cap $543.9M · Next earnings Thu 5 Nov

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	20.8%	30.3%	59.8%	42.1%	85.1%	73.3%	—	—
Operating margin	−785.4%	−1,327.1%	−302.0%	−311.6%	−758.2%	−975.9%	−975.9%	+0.0 pts
Net margin	−787.0%	−1,344.0%	−292.1%	−283.1%	−705.5%	−829.6%	−829.6%	+0.0 pts
EBITDA margin	−728.1%	−953.4%	−283.5%	−369.5%	−276.3%	−823.8%	—	—
Return on equity	−135.5%	−46.0%	−44.0%	−56.3%	−84.9%	−63.0%	−63.0%	+0.0 pts
Return on assets	−72.1%	−36.2%	−34.1%	−44.8%	−59.9%	−40.5%	−40.5%	+0.0 pts
Return on capital employed	−91.1%	−39.3%	−38.6%	−58.5%	−75.2%	−57.9%	—	—
Debt / equity	0.3×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Debt / assets	15.9%	0.3%	0.3%	0.2%	0.0%	1.3%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	3.9×	8.9×	10.6×	4.2×	4.0×	5.3×	5.3×	+0.0%
Quick ratio	3.9×	8.9×	10.6×	4.2×	4.0×	5.3×	—	—
Cash ratio	1.5×	1.2×	2.1×	1.3×	0.8×	0.7×	0.7×	+0.0%
Asset turnover	0.1×	0.0×	0.1×	0.2×	0.1×	0.0×	—	—
Receivables turnover	8.4×	10.9×	61.5×	104.9×	58.9×	1.4×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—